Auf dieser Seite
KOD Kodiak Sciences Inc - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$94,45
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$10,9452-Wochen-Tief
$104,0052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$5.93B
P/E
-21.9
EPS
$-4.32
Ihre Abzeichen
52W-Spanne
$11–$104
Analystenbewertung
BUY
Kursziel
$117
P/E
-21.9
ROE
-202.0%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
KOD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$94.45
Marktkapitalisierung (MRQ)
$5.93B
P/E
-21.9
EPS
$-4.32
ROE
-202.0%
52W-Spanne
$11–$104
KOD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Kodiak Sciences Inc - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter141
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-4.322020-12-31 → 2025-12-31
Freier Cashflow$-137M2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | KOD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -21.95-Jahres-Durchschnitt ≈-5.5 | ≈-5.5 | · | · | |
| K/B (MRQ) | 97.15-Jahres-Durchschnitt ≈4.5 | ≈4.5 | 12.5 | Überbewertet | |
| Kurs / FCF (TTM) | -37.15-Jahres-Durchschnitt ≈-8.3 | ≈-8.3 | · | · | |
| Kurs / Cashflow (TTM) | -37.45-Jahres-Durchschnitt ≈-8.8 | ≈-8.8 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 37.15-Jahres-Durchschnitt ≈4.5 | ≈4.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | KOD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -66.9%5-Jahres-Durchschnitt ≈-45.0% | ≈-45.0% | -23.8% | Schwach | |
| ROE | -202.0%5-Jahres-Durchschnitt ≈-102.0% | ≈-102.0% | -56.0% | Schwach | |
| ROIC | -149.0%5-Jahres-Durchschnitt ≈-99.2% | ≈-99.2% | -55.8% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | KOD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.55-Jahres-Durchschnitt ≈7.8 | ≈7.8 | 4.3 | Geringe Liquidität | |
| Quick Ratio | 4.65-Jahres-Durchschnitt ≈7.7 | ≈7.7 | 3.1 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-2.9%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 13, 2026 | $-1.05 | $-0.97 | -8.7% |
| 31. März 2026 | Mai 20, 2026 | $-0.94 | $-1.02 | 8.1% |
| 31. Dezember 2025 | $-1.04 | $-1.06 | 2.2% | |
| 30. September 2025 | $-1.16 | $-1.04 | -11.6% | |
| 30. Juni 2025 | $-1.03 | $-1.08 | 4.4% | |
| 31. März 2025 | $-1.09 | $-0.90 | -20.7% | |
| 31. Dezember 2024 | $-0.84 | $-0.89 | 6.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $182M | $126M | $206M | $268M | $217M | $107M | $38M | $19M | $22M | |
| SG&A Expense | $52M | $61M | $71M | $74M | $50M | $29M | $12M | $8M | $3M | |
| Operating Expenses | $234M | $187M | $277M | $341M | $267M | $136M | $49M | $26M | $26M | |
| Operating Income | $-234M | $-187M | $-277M | $-341M | $-267M | $-136M | $-49M | $-26M | $-26M | |
| Interest Expense | $0 | $0 | $13.0K | $18.0K | $47.0K | $25.0K | $8.0K | $6M | $1M | |
| Interest Income | $5M | $11M | $17M | $7M | $298.0K | $3M | $2M | $617.0K | $29.0K | |
| Other Non-op | $-96.0K | $-506.0K | $110.0K | $503.0K | $-190.0K | $-30.0K | $265.0K | $-5M | $-1M | |
| Pretax Income | $-230M | $-176M | $-260M | $-334M | $-267M | $-133M | $-47M | $-41M | $-28M | |
| Income Tax | $52.0K | $20.0K | $33.0K | $33.0K | $74.0K | $14.0K | · | · | · | |
| Net Income | $-230M | $-176M | $-260M | $-334M | $-267M | $-133M | $-47M | $-41M | $-28M | |
| EPS (Basic) | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 | $-2.91 | · | · | · | |
| EPS (Diluted) | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 | $-2.91 | · | · | · | |
| Shares (Basic) | 53,208,311 | 52,583,148 | 52,414,256 | 52,249,620 | 51,788,918 | 45,741,845 | · | · | · | |
| Shares (Diluted) | 53,208,311 | 52,583,148 | 52,414,256 | 52,249,620 | 51,788,918 | 45,741,845 | · | · | · | |
| EBITDA | $-234M | $-187M | $-277M | $-341M | $-267M | $-136M | $-49M | $-26M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $210M | $168M | $286M | $190M | $732M | $944M | $212M | $88M | $1M | |
| Short-term Investments | · | · | $0 | $288M | $0 | $25M | $125M | · | · | |
| Prepaid Expense | $5M | $4M | $4M | $7M | $3M | $3M | $3M | $2M | $200.0K | |
| Current Assets | $215M | $172M | $289M | $486M | $735M | $972M | $339M | $90M | $2M | |
| PP&E (Net) | $85M | $102M | $120M | $56M | $41M | $5M | $996.0K | $1M | $2M | |
| PP&E (Gross) | $145M | $143M | $143M | $63M | $44M | $7M | $3M | $3M | $3M | |
| Accum. Depreciation | $59M | $41M | $23M | $7M | $3M | $2M | $2M | $2M | $1M | |
| Other Non-current Assets | $9M | $9M | $9M | $59M | $55M | $10M | $5M | $503.0K | · | |
| Total Assets | $352M | $336M | $479M | $667M | $904M | $1.07B | $359M | $92M | $3M | |
| Accounts Payable | $13M | $4M | $14M | $9M | $12M | $9M | $3M | $1M | $3M | |
| Accrued Liabilities | $21M | $11M | $18M | $33M | $48M | $20M | $9M | $4M | $6M | |
| Current Liabilities | $46M | $26M | $42M | $52M | $65M | $31M | $12M | $5M | $9M | |
| Capital Leases | $47M | $60M | $72M | $78M | $76M | $75M | $2M | · | · | |
| Other Non-current Liabilities | · | · | $0 | $162.0K | $211.0K | $256.0K | $295.0K | $530.0K | $586.0K | |
| Total Liabilities | $194M | $185M | $214M | $230M | $241M | $207M | $14M | $5M | $22M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $1.0K | |
| Retained Earnings | $-1.56B | $-1.33B | $-1.15B | $-892M | $-558M | $-291M | $-158M | $-111M | $-69M | |
| AOCI | · | · | $0 | $-1M | $0 | $53.0K | $10.0K | · | · | |
| Stockholders' Equity | $157M | $150M | $266M | $436M | $663M | $861M | $345M | $87M | $-69M | |
| Liabilities + Equity | $352M | $336M | $479M | $667M | $904M | $1.07B | $359M | $92M | $3M | |
| Shares Outstanding | 61,758,454 | 52,726,916 | 52,508,602 | 52,333,850 | 51,826,257 | 51,112,302 | 44,413,404 | 36,829,857 | 7,936,434 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $59M | $60M | $89M | $106M | $61M | $31M | $6M | $3M | $275.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-136M | $-117M | $-154M | $-206M | $-182M | $-83M | $-39M | $-29M | $-18M | |
| CapEx | $506.0K | $375.0K | $41M | $37M | $17M | $4M | $437.0K | $78.0K | $209.0K | |
| Investing Cash Flow | $-506.0K | $-755.0K | $249M | $-337M | $-39M | $105M | $-137M | $-581.0K | $-209.0K | |
| Stock Issued | · | · | · | $0 | $0 | $612M | $298M | $84M | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | $0 | · | $612M | $298M | $84M | · | |
| Financing Cash Flow | $178M | $501.0K | $31.0K | $2M | $8M | $717M | $300M | $116M | $10M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-137M | $-118M | $-196M | $-243M | $-199M | $-87M | $-40M | $-29M | · | |
| Levered FCF | $-137M | $-118M | $-196M | $-243M | $-199M | $-87M | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -66.9% | -43.2% | -45.5% | -42.5% | -27.1% | -18.7% | -21.0% | -86.9% | · | |
| ROE | -202.0% | -105.0% | -91.7% | -72.9% | -38.4% | -23.3% | -23.4% | 1184.6% | · | |
| ROIC | -149.0% | -124.3% | -104.3% | -78.3% | -40.3% | -15.8% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 6.7 | 6.9 | 9.3 | 11.4 | 30.9 | 29.0 | 18.7 | · | |
| Quick Ratio | 4.6 | 6.6 | 6.8 | 9.1 | 11.3 | 30.8 | 28.7 | 18.3 | · | |
| Interest Coverage | · | · | -21332.4 | -18965.5 | -12138.7 | -5440.3 | -6148.8 | -4.8 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.55 | $2.86 | $5.06 | $8.33 | $12.80 | $16.84 | $7.78 | $2.36 | · | |
| Cash Flow / Share | $-2.56 | $-2.23 | $-2.94 | $-3.95 | · | · | · | · | · | |
| Cash / Share | $3.40 | $3.20 | $5.44 | $3.64 | $14.11 | $18.48 | $4.77 | $2.40 | · | |
| EPS (TTM) | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 | $-2.91 | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-230M | $-176M | $-260M | $-334M | $-267M | $-133M | $-47M | $-41M | · | |
| Market Cap | $1.73B | $522M | $160M | $375M | $4.39B | $7.51B | $3.20B | $261M | · | |
| P/E | -6.5 | -3.0 | -0.6 | -1.1 | -16.4 | -50.5 | · | · | · | |
| P/B | 11.0 | 3.5 | 0.6 | 0.9 | 6.6 | 8.7 | 9.3 | 3.0 | · | |
| P / Tangible Book | 11.0 | 3.5 | 0.6 | 0.9 | 6.6 | 8.7 | · | · | · | |
| P / Cash Flow | -12.7 | -4.5 | -1.0 | -1.8 | -24.1 | -90.0 | -81.6 | -9.0 | · | |
| P / FCF | -12.6 | -4.4 | -0.8 | -1.5 | -22.0 | -86.1 | -80.7 | -9.0 | · | |
| Earnings Yield | -15.4% | -33.7% | -163.5% | -89.2% | -6.1% | -2.0% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $56M | $49M | $45M | $50M | $43M | $44M | $32M | $32M | $33M | $30M | $36M | $67M | $57M | $62M | $74M | $76M | |
| SG&A Expense | $11M | $11M | $12M | $12M | $13M | $15M | $14M | $15M | $15M | $16M | $18M | $18M | $18M | $18M | $18M | $20M | |
| Operating Expenses | $67M | $60M | $57M | $62M | $56M | $59M | $46M | $47M | $48M | $46M | $54M | $85M | $75M | $79M | $92M | $96M | |
| Operating Income | $-67M | $-60M | $-57M | $-62M | $-56M | $-59M | $-46M | $-47M | $-48M | $-46M | $-54M | $-85M | $-75M | $-79M | $-92M | $-96M | |
| Interest Expense | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $5.0K | $4.0K | $4.0K | $4.0K | $5.0K | $5.0K | |
| Interest Income | $1M | $2M | $757.0K | $917.0K | $1M | $2M | $2M | $3M | $3M | $3M | $5M | $5M | $4M | $2M | $1M | $76.0K | |
| Other Non-op | $-60.0K | $-22.0K | $-40.0K | $-22.0K | $-44.0K | $10.0K | $-56.0K | $-25.0K | $-88.0K | $-337.0K | $-38.0K | $-35.0K | $222.0K | $-40.0K | $-49.0K | $-13.0K | |
| Net Income | $-66M | $-58M | $-57M | $-61M | $-54M | $-57M | $-44M | $-44M | $-45M | $-43M | $-50M | $-80M | $-71M | $-77M | $-91M | $-96M | |
| EPS (Basic) | $-1.05 | $-0.94 | $-1.04 | $-1.16 | $-1.03 | $-1.09 | $-0.83 | $-0.84 | $-0.86 | $-0.82 | $-0.95 | $-1.53 | $-1.35 | $-1.47 | $-1.74 | $-1.83 | |
| EPS (Diluted) | $-1.05 | $-0.94 | $-1.04 | $-1.16 | $-1.03 | $-1.09 | $-0.83 | $-0.84 | $-0.86 | $-0.82 | $-0.95 | $-1.53 | $-1.35 | $-1.47 | $-1.74 | $-1.83 | |
| Shares (Basic) | 62,628,596 | 61,859,485 | · | 52,859,308 | 52,779,162 | 52,746,318 | · | 52,616,183 | 52,554,215 | 52,510,460 | 52,455,620 | 52,378,729 | 52,337,603 | 52,288,257 | 52,218,773 | 52,172,918 | |
| Shares (Diluted) | 62,628,596 | 61,859,485 | · | 52,859,308 | 52,779,162 | 52,746,318 | · | 52,616,183 | 52,554,215 | 52,510,460 | 52,455,620 | 52,378,729 | 52,337,603 | 52,288,257 | 52,218,773 | 52,172,918 | |
| EBITDA | $-67M | $-60M | · | $-62M | $-56M | $-59M | · | $-47M | $-48M | $-46M | $-54M | $-85M | $-75M | $-79M | $-92M | $-96M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $170M | $210M | $72M | $104M | $139M | $168M | $198M | $219M | $246M | $346M | $379M | $317M | $178M | $173M | $672M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $105M | $359M | $425M | · | |
| Prepaid Expense | $5M | $6M | $5M | $4M | $4M | $4M | $4M | $5M | $5M | $6M | $5M | $8M | $10M | $7M | $6M | $10M | |
| Current Assets | $131M | $175M | $215M | $76M | $108M | $143M | $172M | $202M | $225M | $252M | $351M | $387M | $431M | $545M | $604M | $682M | |
| PP&E (Net) | $78M | $82M | $85M | $89M | $93M | $98M | $102M | $107M | $111M | $116M | $125M | $130M | $135M | $56M | $55M | $49M | |
| PP&E (Gross) | · | · | $145M | · | · | · | $143M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $59M | · | · | · | $41M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $56M | $54M | $48M | |
| Total Assets | $257M | $306M | $352M | $218M | $257M | $298M | $336M | $373M | $402M | $435M | $548M | $590M | $640M | $724M | $782M | $850M | |
| Accounts Payable | $13M | $11M | $13M | $10M | $5M | $7M | $4M | $3M | $2M | $2M | $39M | $12M | $6M | $16M | $21M | $13M | |
| Accrued Liabilities | $30M | $27M | $21M | $20M | $15M | $13M | $11M | $11M | $9M | $13M | $23M | $54M | $55M | $41M | $43M | $58M | |
| Current Liabilities | $53M | $50M | $46M | $42M | $31M | $31M | $26M | $24M | $21M | $25M | $71M | $74M | $69M | $66M | $70M | $76M | |
| Capital Leases | $43M | $44M | $47M | $50M | $54M | $57M | $60M | $63M | $66M | $69M | $74M | $77M | $79M | $79M | $81M | $76M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $175.0K | $187.0K | $199.0K | |
| Total Liabilities | $196M | $194M | $194M | $194M | $186M | $189M | $185M | $187M | $187M | $194M | $245M | $251M | $248M | $244M | $251M | $253M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-1.68B | $-1.62B | $-1.56B | $-1.50B | $-1.44B | $-1.39B | $-1.33B | $-1.28B | $-1.24B | $-1.20B | $-1.09B | $-1.04B | $-963M | $-822M | $-745M | $-654M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $-96.0K | $-3M | $-2M | · | |
| Stockholders' Equity | $61M | $112M | $157M | $24M | $70M | $109M | $150M | $185M | $215M | $241M | $302M | $338M | $393M | $480M | $531M | $597M | |
| Liabilities + Equity | $257M | $306M | $352M | $218M | $257M | $298M | $336M | $373M | $402M | $435M | $548M | $590M | $640M | $724M | $782M | $850M | |
| Shares Outstanding | 62,830,860 | 62,155,685 | 61,758,454 | 52,998,561 | 52,821,689 | 52,751,875 | 52,726,916 | 52,623,087 | 52,614,729 | 52,523,447 | 52,467,291 | 52,453,163 | 52,344,741 | 52,304,154 | 52,024,621 | 51,939,881 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $12M | $12M | $13M | $14M | $16M | $16M | $9M | $15M | $18M | $18M | $14M | $26M | $26M | $26M | $26M | $28M | |
| Operating Cash Flow | $-46M | $-40M | $-39M | $-33M | $-35M | $-29M | $-30M | $-21M | $-26M | $-40M | $-33M | $-42M | $-47M | $-53M | $-55M | $-43M | |
| CapEx | $352.0K | $942.0K | $43.0K | $60.0K | $133.0K | $270.0K | $124.0K | $180.0K | $49.0K | $22.0K | $226.0K | $1M | $12M | $8M | $8M | $17M | |
| Investing Cash Flow | $-352.0K | $-942.0K | $-43.0K | $-60.0K | $-133.0K | $-270.0K | $-124.0K | $-205.0K | $-260.0K | $-166.0K | $-226.0K | $104M | $173M | $59M | $-444M | $-18M | |
| Financing Cash Flow | $3M | $619.0K | $177M | $813.0K | $120.0K | $124.0K | $404.0K | $0 | $59.0K | $38.0K | $-12.0K | $170.0K | $-3.0K | $78.0K | $54.0K | $2M | |
| Free Cash Flow | · | $-41M | · | · | · | $-29M | · | · | · | $-40M | · | · | $-59M | · | · | $-61M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -25.6% | -19.3% | · | -20.8% | -16.5% | -15.7% | · | -9.6% | -9.1% | -8.0% | -7.9% | -11.7% | -9.5% | -9.2% | -10.2% | -10.2% | |
| ROE | -99.9% | -52.6% | · | -58.8% | -38.1% | -32.8% | · | -18.0% | -16.3% | -13.6% | -12.8% | -18.4% | -14.3% | -12.8% | -13.8% | -13.5% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 3.5 | · | 1.8 | 3.5 | 4.6 | · | 8.4 | 10.6 | 10.1 | 5.0 | 5.2 | 6.3 | 8.3 | 8.7 | 8.9 | |
| Quick Ratio | 2.4 | 3.4 | · | 1.7 | 3.4 | 4.5 | · | 8.2 | 10.3 | 9.9 | 4.9 | 5.1 | 6.1 | 8.2 | 8.6 | 8.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -10900.0 | -21208.0 | -18653.8 | -19869.5 | -18413.6 | -19153.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.97 | $1.80 | · | $0.45 | $1.33 | $2.06 | · | $3.52 | $4.08 | $4.59 | $5.76 | $6.45 | $7.50 | $9.17 | $10.21 | $11.50 | |
| Cash Flow / Share | · | $-0.65 | · | · | · | $-0.55 | · | · | · | $-0.75 | · | · | $-0.90 | · | · | · | |
| Cash / Share | $2.00 | $2.73 | · | $1.36 | $1.97 | $2.63 | · | $3.76 | $4.17 | $4.68 | $6.59 | $7.22 | $6.05 | $3.41 | $3.32 | $12.93 | |
| EPS (TTM) | $-4.19 | $-4.17 | · | $-4.11 | $-3.79 | $-3.62 | · | $-3.66 | $-3.77 | $-4.44 | $-5.18 | $-5.70 | $-5.91 | $-6.84 | $-6.67 | $-6.01 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-242M | $-231M | · | $-217M | $-200M | $-191M | · | $-192M | $-198M | $-233M | $-271M | $-298M | $-309M | $-357M | $-347M | $-312M | |
| Market Cap | $2.45B | $2.37B | · | $868M | $197M | $148M | · | $137M | $124M | $276M | $94M | $362M | $325M | $405M | $397M | $401M | |
| P/E | -9.3 | -9.1 | · | -4.0 | -1.0 | -0.8 | · | -0.7 | -0.6 | -1.2 | -0.3 | -1.2 | -1.0 | -1.1 | -1.1 | -1.3 | |
| P/B | 40.1 | 21.1 | · | 36.6 | 2.8 | 1.4 | · | 0.7 | 0.6 | 1.1 | 0.3 | 1.1 | 0.8 | 0.8 | 0.7 | 0.7 | |
| P / Tangible Book | 40.1 | 21.1 | · | 36.6 | 2.8 | 1.4 | · | 0.7 | 0.6 | 1.1 | 0.3 | 1.1 | 0.8 | 0.8 | 0.7 | 0.7 | |
| P / Cash Flow | · | -59.2 | · | · | · | -5.1 | · | · | · | -7.0 | · | · | -6.9 | · | · | -9.3 | |
| Earnings Yield | -10.8% | -10.9% | · | -25.1% | -101.6% | -128.8% | · | -140.2% | -160.4% | -84.4% | -287.8% | -82.6% | -95.3% | -88.4% | -87.3% | -77.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-230M | $-176M | $-260M | $-334M | $-267M |
| Verwässerte EPS | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 4.7 | 6.7 | 6.9 | 9.3 | 11.4 |
| Quick Ratio | 4.6 | 6.6 | 6.8 | 9.1 | 11.3 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-137M | $-118M | $-196M | $-243M | $-199M |
Institutionelle Eigentümer (13F) 214 Einreicher · $2.3B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
214
Gehaltener Wert
$2.3B
Neue Positionen
34
Geschlossene Positionen
22
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 34 (-30 vs. Vorquartal) | 22 (+4 vs. Vorquartal) | 90 (+21 vs. Vorquartal) | 59 (+7 vs. Vorquartal) | +1.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $776.051.487 | 19.919.186 | 34,06% | Aktien |
| BlackRock, Inc. | $161.113.431 | 4.135.355 | 7,07% | Aktien |
| STATE STREET CORP | $94.260.486 | 2.419.417 | 4,14% | Aktien |
| GOLDMAN SACHS GROUP INC | $90.231.905 | 2.316.014 | 3,96% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $70.308.463 | 1.804.632 | 3,09% | Aktien |
| BRAIDWELL LP | $69.633.909 | 1.787.318 | 3,06% | Aktien |
| VANGUARD GROUP INC | $64.682.524 | 2.313.395 | 2,84% | Aktien |
| RTW INVESTMENTS, LP | $57.969.909 | 1.487.934 | 2,54% | Aktien |
| Boxer Capital Management, LLC | $57.567.296 | 1.477.600 | 2,53% | Aktien |
| TCG Crossover Management, LLC | $56.318.161 | 1.445.538 | 2,47% | Aktien |
| JANUS HENDERSON GROUP PLC | $50.539.675 | 1.325.457 | 2,22% | Aktien |
| ICONIQ Capital, LLC | $49.345.294 | 1.266.563 | 2,17% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $41.420.974 | 1.062.955 | 1,82% | Aktien |
| Ikarian Capital, LLC | $41.287.080 | 1.059.730 | 1,81% | Aktien |
| Artisan Partners Limited Partnership | $37.714.722 | 968.037 | 1,66% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $30.919.164 | 793.613 | 1,36% | Aktien |
| Board of Trustees of The Leland Stanford Junior University | $26.951.242 | 691.767 | 1,18% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $21.282.134 | 546.256 | 0,93% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20.758.628 | 532.819 | 0,91% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $19.480.000 | 500.000 | 0,85% | Aktien |
| Squadron Capital Management LLC | $19.480.000 | 500.000 | 0,85% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $18.428.119 | 473.001 | 0,81% | Aktien |
| MORGAN STANLEY | $16.948.748 | 435.029 | 0,74% | Aktien |
| BANK OF AMERICA CORP /DE/ | $14.949.303 | 383.709 | 0,66% | Aktien |
| BOONE CAPITAL MANAGEMENT LLC | $14.727.270 | 378.010 | 0,65% | Aktien |
| NORTHERN TRUST CORP | $14.291.579 | 366.827 | 0,63% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13.949.862 | 358.056 | 0,61% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $12.174.462 | 312.595 | 0,53% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $11.375.112 | 291.969 | 0,50% | Aktien |
| FMR LLC | $10.791.298 | 276.984 | 0,47% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $10.344.815 | 265.524 | 0,45% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9.346.504 | 239.900 | 0,41% | Kaufoption |
| DIADEMA PARTNERS LP | $8.497.838 | 218.117 | 0,37% | Aktien |
| Ikarian Capital, LLC | $8.481.592 | 217.700 | 0,37% | Kaufoption |
| D. E. Shaw & Co., Inc. | $8.232.248 | 211.300 | 0,36% | Aktien |
| DIADEMA PARTNERS LP | $7.663.432 | 196.700 | 0,34% | Kaufoption |
| TD Asset Management Inc | $7.563.383 | 194.132 | 0,33% | Aktien |
| PFM Health Sciences, LP | $7.531.552 | 193.315 | 0,33% | Aktien |
| UBS Group AG | $7.406.880 | 190.115 | 0,33% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $7.371.232 | 189.200 | 0,32% | Aktien |
| ALGERT GLOBAL LLC | $7.265.105 | 186.476 | 0,32% | Aktien |
| Nuveen, LLC | $6.807.481 | 174.730 | 0,30% | Aktien |
| CITADEL ADVISORS LLC | $6.137.135 | 157.524 | 0,27% | Aktien |
| Squarepoint Ops LLC | $5.886.778 | 151.098 | 0,26% | Aktien |
| Ghisallo Capital Management LLC | $5.844.000 | 150.000 | 0,26% | Aktien |
| DIADEMA PARTNERS LP | $5.723.224 | 146.900 | 0,25% | Verkaufsoption |
| Bruce & Co., Inc. | $5.649.200 | 145.000 | 0,25% | Aktien |
| FEDERATED HERMES, INC. | $5.612.772 | 144.065 | 0,25% | Aktien |
| PRUDENTIAL FINANCIAL INC | $4.694.485 | 120.495 | 0,21% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $4.444.907 | 114.089 | 0,20% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLC, Baker Bros. Advisors LP, Felix J. Baker, Julian C. Baker | 30. September 2026 | 35,00% | Änderung | Passive Anlage | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×12 Einreichungen | 19. Dezember 2025 | 32,80% | Änderung | Kapitalstruktur | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 9 Insider · 4 Führungskräfte · 6 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Victor Perlroth | Chairman and CEO | 25. September 2026 M | 3.676.062 | 0 | 0 | $0 |
| John A. Borgeson | Chief Financial Officer | 15. Juli 2026 A | 211.930 | 0 | 6 | $-2.220.497 |
| Jason Ehrlich | Chief Medical Officer and Chief Development Officer | 24. Juni 2023 A | 61.924 | 0 | 0 | $0 |
| Hong Liang | SVP, Discovery Medicine | 2. April 2020 S | 130.166 | 0 | 0 | $0 |
| Bassil I Dahiyat | Direktor | 30. Juni 2026 A | · | 0 | 0 | $0 |
| Charles A Bancroft | Direktor | 30. Juni 2026 A | · | 0 | 0 | $0 |
| Richard S Levy | Direktor | 30. Juni 2026 A | 1.000 | 0 | 0 | $0 |
| Taiyin Yang | Direktor | 30. Juni 2026 A | · | 0 | 0 | $0 |
| Robert Profusek | Direktor | 30. Juni 2026 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 29 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,82% | 9.125 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,43% | 50.808 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,41% | 4.423 SH | 2. Oktober 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,14% | 38.803 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,14% | 443.467 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,14% | 70.377 SH | 19. August 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,12% | 694 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,09% | 42.202 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,08% | 369.841 SH | 11. September 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 10.682 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,05% | 18.846 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 226.556 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,04% | 1.011.605 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 475.491 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 93.063 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 14.697 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 1.802 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 23.200 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3.093 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 8.843 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14.520 SH | 10. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 61.260 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 4.260 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.288.755 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.260 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 31. Juli 2026 | N-PORT |
| ISCB · iShares Trust | · | 1.789 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 8.719 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 15.858 SH | 11. September 2026 | Täglich |
KOD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$116.00
+22,8%
2 20,0%
Starker Kauf
7 70,0%
Kauf
1 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-10-03Mittelwert-Ziel $116.67 +23,5%
← Unter allen Zielen
Aktueller Preis $94.45
Tief$96.00
Mittelwert$116.67
Hoch$145.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| KOD | $1.73B | -6.5 | · | · | -202.0% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026